GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Receipts from Customers

Microbix Biosystems (TSX:MBX) Receipts from Customers


View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Receipts from Customers?

Receipts from Customers only applicable to companies reporting Cash Flow from Operations in direct method.


Microbix Biosystems Business Description

Traded in Other Exchanges
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.
Executives
Cameron Lionel Groome Director, Senior Officer
Bo Hollas Director
Steven Trevor Hagerman Senior Officer
Jennifer Anne Stewart Director
James Stuart Currie Senior Officer
Damian Klimaszewski Senior Officer
Kenneth Hughes Senior Officer
Anthony J. Giovinazzo Director
Martin Marino Director
Mark Adrian Luscher Senior Officer
Peter Martin Blecher Director